Document is current
Any future updates will be listed below
-
Authors
Lobo, Elena https://orcid.org/0000-0002-1252-2397
De la Cámara, Concepción
Gracia-García, Patricia
López-Antón, Raúl
Saz, Pedro
Vaquero-Puyuelo, David
Lobo, Antonio
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (94/1562)
Instituto de Salud Carlos III (97/1321E)
Instituto de Salud Carlos III (98/0103)
Instituto de Salud Carlos III (01/0255)
Instituto de Salud Carlos III (03/0815)
Instituto de Salud Carlos III (G03/128)
Instituto de Salud Carlos III (06/0617)
Instituto de Salud Carlos III (PI/19/00948)
National Institute of Mental Health (12/02254)
National Institute of Mental Health (16/00896)
National Institute of Mental Health (PI/19/01874)
Universidad de Zaragoza
- License Information
-
More Information
Article History
Received: 16 July 2025
Accepted: 5 February 2026
First Online: 14 February 2026
Declarations
:
: C. De-la-Cámara received financial support to attend scientific meetings from Janssen, Almirall, Lilly, Lundbeck, Rovi, Esteve, Novartis, AstraZeneca, Pfizer, and Casen Recordati. P. Gracia-García received financial support to attend scientific meetings from Lundbeck, Neuraxpharm, and Esteve. D. Vaquero-Puyuelo received financial support to attend scientific meetings from Rovi, Lundbeck and Casen Recordati. A. Lobo had a consultancy with Janssen and received financial support to attend scientific meetings from Eli Lilly, Bial, and Janssen. None of these activities were related to the current project. For the remaining authors, none was declared.
